Amsterdam institute for Immunology and Infectious Diseases
-
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
on behalf of the T2B! immunity against SARS-CoV-2 study group, 1 Dec 2023, In: BMC Infectious Diseases. 23, 1, 332.Research output: Contribution to journal › Article › Academic › peer-review
-
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Wieske, L., Stalman, E. W., van Dam, P. J. K., Kummer, L. Y., Steenhuis, M., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G., van der Kooi, A., Raaphorst, J., Löwenberg, M., Takkenberg, B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., & 38 others , 1 Jun 2023, In: Annals of the rheumatic diseases. 82, 6, p. 883-885 3 p., ard-2022-223464.Research output: Contribution to journal › Review article › Academic › peer-review
-
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
the T2B! immunity against SARS-CoV-2 study group, 1 Feb 2023, In: Journal of autoimmunity. 135, 102984.Research output: Contribution to journal › Article › Academic › peer-review
- All publications